Back to Search Start Over

Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment.

Authors :
Krishnamachary B
Mironchik Y
Jacob D
Goggins E
Kakkad S
Ofori F
Dore-Savard L
Bharti SK
Wildes F
Penet MF
Black ME
Bhujwalla ZM
Source :
Neoplasia (New York, N.Y.) [Neoplasia] 2020 Dec; Vol. 22 (12), pp. 679-688. Date of Electronic Publication: 2020 Oct 23.
Publication Year :
2020

Abstract

Hypoxia is frequently observed in human prostate cancer, and is associated with chemoresistance, radioresistance, metastasis, and castrate-resistance. Our purpose in these studies was to perform hypoxia theranostics by combining in vivo hypoxia imaging and hypoxic cancer cell targeting in a human prostate cancer xenograft. This was achieved by engineering PC3 human prostate cancer cells to express luciferase as well as a prodrug enzyme, yeast cytosine deaminase, under control of hypoxic response elements (HREs). Cancer cells display an adaptive response to hypoxia through the activation of several genes mediated by the binding of hypoxia inducible factors (HIFs) to HRE in the promoter region of target gene that results in their increased transcription. HIFs promote key steps in tumorigenesis, including angiogenesis, metabolism, proliferation, metastasis, and differentiation. HRE-driven luciferase expression allowed us to detect hypoxia in vivo to time the administration of the nontoxic prodrug 5-fluorocytosine that was converted by yeast cytosine deaminase, expressed under HRE regulation, to the chemotherapy agent 5-fluorouracil to target hypoxic cells. Conversion of 5-fluorocytosine to 5-fluorouracil was detected in vivo by <superscript>19</superscript> F magnetic resonance spectroscopy. Morphological and immunohistochemical staining and molecular analyses were performed to characterize tumor microenvironment changes in cancer-associated fibroblasts, cell viability, collagen 1 fiber patterns, and HIF-1α. These studies expand our understanding of the effects of eliminating hypoxic cancer cells on the tumor microenvironment and in reducing stromal cell populations such as cancer-associated fibroblasts.<br /> (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1476-5586
Volume :
22
Issue :
12
Database :
MEDLINE
Journal :
Neoplasia (New York, N.Y.)
Publication Type :
Academic Journal
Accession number :
33142234
Full Text :
https://doi.org/10.1016/j.neo.2020.10.001